Suchergebnisse - "Costa, Luciano"

PubPharm (589)

1

Subsequent therapy and outcomes in patients with newly diagnosed multiple myeloma experiencing disease progression after quadruplet combinations

enthalten in: British journal of haematology | 2024

von Ravi, G. | Bal, S. | Joiner, L. | +5

2

Plain Language Summary of the KarMMa-3 study of ide-cel or standard of care regimens in people with relapsed or refractory multiple myeloma

enthalten in: Future oncology (London, England) | 2024

von Rodriguez-Otero, P. | Ailawadhi, S. | Arnulf, B. | +19

3

Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk

enthalten in: Blood cancer journal | 2024

von Callander, N. | Silbermann, R. | Kaufman, J. | +33

4

Real-World Data on Therapies for Relapsed or Refractory Multiple Myeloma : Key Data from ASH 2023-A Podcast

enthalten in: Advances in therapy | 2024

von Costa, L. | Rodriguez-Otero, P.

5

Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone : Patient-reported outcomes from GRIFFIN

enthalten in: American journal of hematology | 2024

von Silbermann, R. | Laubach, J. | Kaufman, J. | +23

6

Low skeletal muscle mass and treatment outcomes among adults with haematologic malignancies : A systematic review and meta-analysis

enthalten in: Journal of cachexia, sarcopenia and muscle | 2024

von Anabtawi, N. | Pasala, M. | Grimshaw, A. | +9

7

A theoretical study on radical scavenging activity of phenolic derivatives naturally found within Alternaria alternata extract

enthalten in: Organic & biomolecular chemistry | 2024

von Abraham, A. | Panneerselvam, M. | Ebenezer, C. | +2

8

Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myeloma

enthalten in: Future oncology (London, England) | 2024

von Costa, L. | LeBlanc, T. | Tesch, H. | +10

9

Bridging treatment prior to chimeric antigen receptor T-cell therapy in multiple myeloma

enthalten in: British journal of haematology | 2024

von Bal, S. | Costa, L.

10

Alterations in chromosome 1q in multiple myeloma randomized clinical trials : a systematic review

enthalten in: Blood cancer journal | 2024

von Neupane, K. | Fortuna, G. | Dahal, R. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[59]